F.L. Putnam Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.69M Sell
20,348
-2,013
-9% -$167K 0.03% 262
2025
Q1
$1.81M Sell
22,361
-17,752
-44% -$1.44M 0.03% 250
2024
Q4
$3.61M Buy
40,113
+18,555
+86% +$1.67M 0.07% 187
2024
Q3
$2.13M Buy
21,558
+2,825
+15% +$279K 0.04% 242
2024
Q2
$1.74M Buy
18,733
+1,099
+6% +$102K 0.03% 258
2024
Q1
$1.67M Buy
+17,634
New +$1.67M 0.04% 218
2021
Q4
Sell
-1,855
Closed -$233K 420
2021
Q3
$233K Sell
1,855
-478
-20% -$60K 0.01% 376
2021
Q2
$316K Sell
2,333
-1,212
-34% -$164K 0.01% 337
2021
Q1
$481K Sell
3,545
-10
-0.3% -$1.36K 0.02% 253
2020
Q4
$500K Sell
3,555
-5
-0.1% -$703 0.02% 227
2020
Q3
$397K Sell
3,560
-25
-0.7% -$2.79K 0.02% 223
2020
Q2
$401K Sell
3,585
-304
-8% -$34K 0.02% 222
2020
Q1
$301K Sell
3,889
-1,535
-28% -$119K 0.02% 234
2019
Q4
$516K Hold
5,424
0.03% 214
2019
Q3
$414K Buy
5,424
+3,579
+194% +$273K 0.03% 209
2019
Q2
$162K Buy
+1,845
New +$162K 0.01% 231
2018
Q4
Sell
-2,694
Closed -$258K 233
2018
Q3
$258K Sell
2,694
-100
-4% -$9.58K 0.02% 199
2018
Q2
$266K Sell
2,794
-345
-11% -$32.8K 0.03% 192
2018
Q1
$275K Sell
3,139
-106
-3% -$9.29K 0.03% 210
2017
Q4
$275K Sell
3,245
-320
-9% -$27.1K 0.03% 199
2017
Q3
$309K Buy
+3,565
New +$309K 0.03% 190
2017
Q1
$266K Hold
3,835
0.03% 195
2016
Q4
$227K Sell
3,835
-1,015
-21% -$60.1K 0.03% 190
2016
Q3
$322K Hold
4,850
0.04% 162
2016
Q2
$262K Buy
+4,850
New +$262K 0.03% 155
2016
Q1
Sell
-16,689
Closed -$1.17M 177
2015
Q4
$1.17M Sell
16,689
-10,833
-39% -$761K 0.14% 108
2015
Q3
$1.71M Sell
27,522
-1,323
-5% -$82.3K 0.21% 89
2015
Q2
$2.43M Sell
28,845
-450
-2% -$37.8K 0.27% 81
2015
Q1
$2.2M Sell
29,295
-7,806
-21% -$587K 0.25% 84
2014
Q4
$2.31M Sell
37,101
-786
-2% -$48.9K 0.27% 84
2014
Q3
$1.97M Sell
37,887
-540
-1% -$28.1K 0.23% 95
2014
Q2
$1.97M Sell
38,427
-20,109
-34% -$1.03M 0.23% 100
2014
Q1
$2.78M Sell
58,536
-4,743
-7% -$225K 0.33% 90
2013
Q4
$2.75M Sell
63,279
-3,978
-6% -$173K 0.33% 90
2013
Q3
$2.9M Buy
+67,257
New +$2.9M 0.39% 83